ATP-dependent Transport of Vinblastine in Vesicles from Human Multidrug-resistant Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1988 May 1

PMID 3368466

Citations 112

Authors

M Horio

M M Gottesman

I Pastan

Affiliations

Soon will be listed here.

Abstract

Resistance of human cancer cells to multiple cytotoxic hydrophobic agents (multidrug resistance) is due to overexpression of the "MDR1" gene, whose product is the plasma membrane P-glycoprotein. Plasma membrane vesicles partially purified from multidrug-resistant human KB carcinoma cells, but not from drug-sensitive cells, accumulate [3H]vinblastine in an ATP-dependent manner. This transport is osmotically sensitive, with an apparent Km of 38 microM for ATP and of approximately equal to 2 microM for vinblastine. The nonhydrolyzable analog adenosine 5'-[beta, gamma-imido]triphosphate does not substitute for ATP but is a competitive inhibitor of ATP for the transport process. Vanadate, an ATPase inhibitor, is a potent noncompetitive inhibitor of transport. These results indicate that hydrolysis of ATP is probably required for active transport of vinblastine. Several other drugs to which multidrug-resistant cell lines are resistant inhibit transport, with relative potencies as follows: vincristine greater than actinomycin D greater than daunomycin greater than colchicine = puromycin. Verapamil and quinidine, which reverse the multidrug-resistance phenotype, are good inhibitors of the transport process. These results confirm that multidrug-resistant cells express an energy-dependent plasma membrane transporter for hydrophobic drugs, and establish a system for the detailed biochemical analysis of this transport process.

Citing Articles

Recent advances of tryptanthrin and its derivatives as potential anticancer agents.

Zhou X RSC Med Chem. 2024; 15(4):1127-1147.

PMID: 38665827 PMC: 11042161. DOI: 10.1039/d3md00698k.

Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance.

Malik S, Sikander M, Wahid M, Dhasmana A, Sarwat M, Khan S Cancer Metastasis Rev. 2024; 43(3):981-999.

PMID: 38498072 DOI: 10.1007/s10555-024-10177-8.

Structure-ATPase Activity Relationship of Rhodamine Derivatives as Potent Inhibitors of P-Glycoprotein CmABCB1.

Miwa S, Takikawa H, Takeuchi R, Mizunuma R, Matsuoka K, Ogawa H ACS Med Chem Lett. 2024; 15(2):287-293.

PMID: 38352840 PMC: 10860176. DOI: 10.1021/acsmedchemlett.3c00526.

Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolism.

Witta S, Collins K, Ramirez D, Mannheimer J, Wittenburg L, Gustafson D Pharmacol Res Perspect. 2023; 11(1):e01052.

PMID: 36631976 PMC: 9834611. DOI: 10.1002/prp2.1052.

Emerging consensus on the mechanism of polyspecific substrate recognition by the multidrug transporter P-glycoprotein.

Xia D, Zhou F, Esser L Cancer Drug Resist. 2022; 2(3):471-489.

PMID: 35582581 PMC: 8992534. DOI: 10.20517/cdr.2019.22.

References

Dano K . Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta. 1973; 323(3):466-83. DOI: 10.1016/0005-2736(73)90191-0. View

Gottesman M, Pastan I . Resistance to multiple chemotherapeutic agents in human cancer cells. Trends Pharmacol Sci. 1988; 9(2):54-8. DOI: 10.1016/0165-6147(88)90117-4. View

Kartner N, Riordan J, Ling V . Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science. 1983; 221(4617):1285-8. DOI: 10.1126/science.6137059. View

Akiyama S, Fojo A, Hanover J, Pastan I, Gottesman M . Isolation and genetic characterization of human KB cell lines resistant to multiple drugs. Somat Cell Mol Genet. 1985; 11(2):117-26. DOI: 10.1007/BF01534700. View

Shen D, Fojo A, Chin J, Roninson I, Richert N, Pastan I . Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science. 1986; 232(4750):643-5. DOI: 10.1126/science.3457471. View

Scotto K, Biedler J, Melera P . Amplification and expression of genes associated with multidrug resistance in mammalian cells. Science. 1986; 232(4751):751-5. DOI: 10.1126/science.2421411. View

Shen D, Cardarelli C, Hwang J, Cornwell M, Richert N, Ishii S . Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem. 1986; 261(17):7762-70. View

Cornwell M, Gottesman M, Pastan I . Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. J Biol Chem. 1986; 261(17):7921-8. View

Cornwell M, Safa A, Felsted R, Gottesman M, Pastan I . Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc Natl Acad Sci U S A. 1986; 83(11):3847-50. PMC: 323621. DOI: 10.1073/pnas.83.11.3847. View

10.

Roninson I, Chin J, Choi K, Gros P, Housman D, Fojo A . Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A. 1986; 83(12):4538-42. PMC: 323769. DOI: 10.1073/pnas.83.12.4538. View

11.

Willingham M, Cornwell M, Cardarelli C, Gottesman M, Pastan I . Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. Cancer Res. 1986; 46(11):5941-6. View

12.

Gros P, Croop J, Housman D . Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell. 1986; 47(3):371-80. DOI: 10.1016/0092-8674(86)90594-5. View

13.

Chen C, Chin J, Ueda K, Clark D, Pastan I, Gottesman M . Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 1986; 47(3):381-9. DOI: 10.1016/0092-8674(86)90595-7. View

14.

Gros P, Ben Neriah Y, Croop J, Housman D . Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 1986; 323(6090):728-31. DOI: 10.1038/323728a0. View

15.

van der Bliek A, van der Velde-Koerts T, Ling V, Borst P . Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line. Mol Cell Biol. 1986; 6(5):1671-8. PMC: 367694. DOI: 10.1128/mcb.6.5.1671-1678.1986. View

16.

Gerlach J, Endicott J, Juranka P, Henderson G, Sarangi F, Deuchars K . Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature. 1986; 324(6096):485-9. DOI: 10.1038/324485a0. View

17.

Fojo A, Ueda K, Slamon D, Poplack D, Gottesman M, Pastan I . Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987; 84(1):265-9. PMC: 304184. DOI: 10.1073/pnas.84.1.265. View

18.

Ma D, Scurr R, Davey R, Mackertich S, Harman D, Dowden G . Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia. Lancet. 1987; 1(8525):135-7. DOI: 10.1016/s0140-6736(87)91969-6. View

19.

Ueda K, Cornwell M, Gottesman M, Pastan I, Roninson I, Ling V . The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun. 1986; 141(3):956-62. DOI: 10.1016/s0006-291x(86)80136-x. View

20.

Cornwell M, Pastan I, Gottesman M . Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem. 1987; 262(5):2166-70. View